Clinical pharmacological study of a plasma-derived factor VIIa and factor X mixture (MC710) in haemophilia patients with inhibitors--phase I trial.
Shirahata A, Fukutake K, Mimaya J, Takamatsu J, Shima M, Hanabusa H, Takedani H, Takashima Y, Matsushita T, Tawa A, Higasa S, Takata N, Sakai M, Kawakami K, Ohashi Y, Saito H.
Shirahata A, et al. Among authors: matsushita t.
Haemophilia. 2012 Jan;18(1):94-101. doi: 10.1111/j.1365-2516.2011.02548.x. Epub 2011 Apr 28.
Haemophilia. 2012.
PMID: 21535327
Clinical Trial.